cyclooxygenase Archives

Without the NHS, There Would Be 70,000 Fewer Deaths.

16 January 2021

SARS-CoV-2 Continues To Weaken. Despite the propaganda, mutant killer of death and apparent overwhelmed hospitals, SARS-CoV-2 continues to attenuate, or weaken, globally. We monitor the data constantly and since August have been highlighting that both active and closed cases have been attenuating and continue to attenuate. As we illustrated at the end of August, Active […]

Antivirals – lessons from the ‘flu jab’.

28 October 2020

That Time Of Year Again. If you have read the previous two articles then you will know the main differences between a vaccine and an antiviral, and why Remdesivir is not an effective antiviral for just about anyone with COVID-19. We have highlighted that antivirals have a pretty patchy record when it comes to their […]

Does Ibuprofen make SARS-CoV-2 better or worse? Here are two strong reasons not to take it.

5 October 2020

Background Back in April we first wrote about a possible connection between the increasingly above-average mortality rates in European countries and their widespread use of non-steroidal anti-inflammatory drugs (NSAIDs) such as Ibuprofen. We raised the question as to whether the cyclooxygenase (COX) enzyme inhibitor function of NSAIDs either intefered with or amplified the angiotensin-converting enzyme […]

It doesn’t look good in Europe

1 April 2020

Currently 22 of the 31 countries & territories with a mortality rate above the worldwide average are in Europe. That’s 71% and surely is more than a coincidence? Usually, countries without access to advanced healthcare and medication are more adversely impacted by a disease but with SARS-CoV-2 the data seems to suggest the opposite. A […]